Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
Identifieur interne : 001178 ( Main/Exploration ); précédent : 001177; suivant : 001179Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
Auteurs : A. Palache [Pays-Bas] ; A. Abelin [France] ; R. Hollingsworth [France] ; W. Cracknell [Australie] ; C. Jacobs [Belgique] ; T. Tsai [États-Unis] ; P. Barbosa [Suisse]Source :
- Vaccine [ 1873-2518 ] ; 2017.
Descripteurs français
- KwdFr :
- Couverture vaccinale (statistiques et données numériques), Enquêtes de santé (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Pandémies (prévention et contrôle), Saisons (MeSH), Santé mondiale (MeSH), Vaccination (statistiques et données numériques), Vaccination (tendances), Vaccins antigrippaux (MeSH).
- MESH :
- prévention et contrôle : Grippe humaine, Pandémies.
- statistiques et données numériques : Couverture vaccinale, Vaccination.
- tendances : Vaccination.
- Enquêtes de santé, Humains, Saisons, Santé mondiale, Vaccins antigrippaux.
English descriptors
- KwdEn :
- MESH :
- chemical : Influenza Vaccines.
- prevention & control : Influenza, Human, Pandemics.
- statistics & numerical data : Vaccination, Vaccination Coverage.
- trends : Vaccination.
- Global Health, Health Surveys, Humans, Seasons.
Abstract
There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.
DOI: 10.1016/j.vaccine.2017.07.053
PubMed: 28754488
Affiliations:
- Australie, Belgique, France, Pays-Bas, Suisse, États-Unis
- Auvergne-Rhône-Alpes, Massachusetts, Rhône-Alpes
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.</title><author><name sortKey="Palache, A" sort="Palache, A" uniqKey="Palache A" first="A" last="Palache">A. Palache</name><affiliation wicri:level="1"><nlm:affiliation>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands. Electronic address: Bram.Palache@ziggo.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp</wicri:regionArea><wicri:noRegion>1381 CP Weesp</wicri:noRegion></affiliation></author><author><name sortKey="Abelin, A" sort="Abelin, A" uniqKey="Abelin A" first="A" last="Abelin">A. Abelin</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName></affiliation></author><author><name sortKey="Hollingsworth, R" sort="Hollingsworth, R" uniqKey="Hollingsworth R" first="R" last="Hollingsworth">R. Hollingsworth</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName></affiliation></author><author><name sortKey="Cracknell, W" sort="Cracknell, W" uniqKey="Cracknell W" first="W" last="Cracknell">W. Cracknell</name><affiliation wicri:level="1"><nlm:affiliation>Seqirus, 63 Poplar Road, Parkville, Victoria 3052, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Seqirus, 63 Poplar Road, Parkville, Victoria 3052</wicri:regionArea><wicri:noRegion>Victoria 3052</wicri:noRegion></affiliation></author><author><name sortKey="Jacobs, C" sort="Jacobs, C" uniqKey="Jacobs C" first="C" last="Jacobs">C. Jacobs</name><affiliation wicri:level="1"><nlm:affiliation>GSK Vaccines, Avenue Fleming 20, 1300 Wavre, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>GSK Vaccines, Avenue Fleming 20, 1300 Wavre</wicri:regionArea><wicri:noRegion>1300 Wavre</wicri:noRegion></affiliation></author><author><name sortKey="Tsai, T" sort="Tsai, T" uniqKey="Tsai T" first="T" last="Tsai">T. Tsai</name><affiliation wicri:level="2"><nlm:affiliation>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Barbosa, P" sort="Barbosa, P" uniqKey="Barbosa P" first="P" last="Barbosa">P. Barbosa</name><affiliation wicri:level="1"><nlm:affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20</wicri:regionArea><wicri:noRegion>1211 Geneva 20</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28754488</idno><idno type="pmid">28754488</idno><idno type="doi">10.1016/j.vaccine.2017.07.053</idno><idno type="wicri:Area/Main/Corpus">001226</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001226</idno><idno type="wicri:Area/Main/Curation">001226</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001226</idno><idno type="wicri:Area/Main/Exploration">001226</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.</title><author><name sortKey="Palache, A" sort="Palache, A" uniqKey="Palache A" first="A" last="Palache">A. Palache</name><affiliation wicri:level="1"><nlm:affiliation>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands. Electronic address: Bram.Palache@ziggo.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp</wicri:regionArea><wicri:noRegion>1381 CP Weesp</wicri:noRegion></affiliation></author><author><name sortKey="Abelin, A" sort="Abelin, A" uniqKey="Abelin A" first="A" last="Abelin">A. Abelin</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName></affiliation></author><author><name sortKey="Hollingsworth, R" sort="Hollingsworth, R" uniqKey="Hollingsworth R" first="R" last="Hollingsworth">R. Hollingsworth</name><affiliation wicri:level="3"><nlm:affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName></affiliation></author><author><name sortKey="Cracknell, W" sort="Cracknell, W" uniqKey="Cracknell W" first="W" last="Cracknell">W. Cracknell</name><affiliation wicri:level="1"><nlm:affiliation>Seqirus, 63 Poplar Road, Parkville, Victoria 3052, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Seqirus, 63 Poplar Road, Parkville, Victoria 3052</wicri:regionArea><wicri:noRegion>Victoria 3052</wicri:noRegion></affiliation></author><author><name sortKey="Jacobs, C" sort="Jacobs, C" uniqKey="Jacobs C" first="C" last="Jacobs">C. Jacobs</name><affiliation wicri:level="1"><nlm:affiliation>GSK Vaccines, Avenue Fleming 20, 1300 Wavre, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>GSK Vaccines, Avenue Fleming 20, 1300 Wavre</wicri:regionArea><wicri:noRegion>1300 Wavre</wicri:noRegion></affiliation></author><author><name sortKey="Tsai, T" sort="Tsai, T" uniqKey="Tsai T" first="T" last="Tsai">T. Tsai</name><affiliation wicri:level="2"><nlm:affiliation>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Barbosa, P" sort="Barbosa, P" uniqKey="Barbosa P" first="P" last="Barbosa">P. Barbosa</name><affiliation wicri:level="1"><nlm:affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20</wicri:regionArea><wicri:noRegion>1211 Geneva 20</wicri:noRegion></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Global Health (MeSH)</term><term>Health Surveys (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (MeSH)</term><term>Influenza, Human (prevention & control)</term><term>Pandemics (prevention & control)</term><term>Seasons (MeSH)</term><term>Vaccination (statistics & numerical data)</term><term>Vaccination (trends)</term><term>Vaccination Coverage (statistics & numerical data)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Couverture vaccinale (statistiques et données numériques)</term><term>Enquêtes de santé (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Pandémies (prévention et contrôle)</term><term>Saisons (MeSH)</term><term>Santé mondiale (MeSH)</term><term>Vaccination (statistiques et données numériques)</term><term>Vaccination (tendances)</term><term>Vaccins antigrippaux (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term><term>Pandémies</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination</term><term>Vaccination Coverage</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Couverture vaccinale</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Global Health</term><term>Health Surveys</term><term>Humans</term><term>Seasons</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Enquêtes de santé</term><term>Humains</term><term>Saisons</term><term>Santé mondiale</term><term>Vaccins antigrippaux</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28754488</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>36</Issue><PubDate><Year>2017</Year><Month>08</Month><Day>24</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.</ArticleTitle><Pagination><MedlinePgn>4681-4686</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(17)30961-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2017.07.053</ELocationID><Abstract><AbstractText>There is no global monitoring system for influenza vaccination coverage, making it difficult to assess progress towards the 2003 World Health Assembly (WHA) vaccination coverage target. In 2008, the IFPMA Influenza Vaccine Supply International Task Force (IVS) developed a survey method to assess the global distribution of influenza vaccine doses as a proxy for vaccination coverage rates. The latest dose distribution data for 2014 and 2015 was used to update previous analyses. Data were confidentially collected and aggregated by the IFPMA Secretariat, and combined with previous IFPMA IVS survey data (2004-2013). Data were available from 201 countries over the 2004-2015 period. A "hurdle" rate was defined as the number of doses required to reach 15.9% of the population in 2008. Overall, the number of distributed doses progressively increased between 2004 and 2011, driven by a 150% increase in AMRO, then plateaued. One percent fewer doses were distributed in 2015 than in 2011. Twenty-three countries were above the hurdle rate in 2015, compared to 15 in 2004, but distribution was highly uneven in and across all WHO regions. Three WHO regions (AMRO, EURO and WPRO) accounted for about 95% of doses distributed. But in EURO and WPRO, distribution rates in 2015 were only marginally higher than in 2004, and in EURO there was an overall downward trend in dose distribution. The vast majority of countries cannot meet the 2003WHA coverage targets and are inadequately prepared for a global influenza pandemic. With only 5% of influenza vaccine doses being distributed to 50% of the world's population, there is urgency to redress the gross inequities in disease prevention and in pandemic preparedness. The 2003WHA resolution must be reviewed and revised and a call issued for the renewed commitment of Member States to influenza vaccination coverage targets.</AbstractText><CopyrightInformation>Copyright © 2017. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Palache</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Consultant at Abbott, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands. Electronic address: Bram.Palache@ziggo.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abelin</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollingsworth</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sanofi Pasteur, 2 Ave Pont Pasteur, Lyon 69007, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cracknell</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Seqirus, 63 Poplar Road, Parkville, Victoria 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GSK Vaccines, Avenue Fleming 20, 1300 Wavre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Takeda Vaccines, 40 Landsdowne Street, Cambridge, MA 02139, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbosa</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>International Federation of Pharmaceutical Manufacturers and Associations, Ch. des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>IFPMA Influenza Vaccine Supply (IFPMA IVS) task force</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="Y">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006306" MajorTopicYN="N">Health Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="Y">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Monitoring and evaluation</Keyword><Keyword MajorTopicYN="Y">Pandemic preparedness</Keyword><Keyword MajorTopicYN="Y">Seasonal influenza</Keyword><Keyword MajorTopicYN="Y">Vaccination coverage rates</Keyword><Keyword MajorTopicYN="Y">Vaccination policy</Keyword><Keyword MajorTopicYN="Y">Vaccine recommendations</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>07</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>07</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28754488</ArticleId><ArticleId IdType="pii">S0264-410X(17)30961-1</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2017.07.053</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>France</li><li>Pays-Bas</li><li>Suisse</li><li>États-Unis</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Massachusetts</li><li>Rhône-Alpes</li></region></list><tree><country name="Pays-Bas"><noRegion><name sortKey="Palache, A" sort="Palache, A" uniqKey="Palache A" first="A" last="Palache">A. Palache</name></noRegion></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Abelin, A" sort="Abelin, A" uniqKey="Abelin A" first="A" last="Abelin">A. Abelin</name></region><name sortKey="Hollingsworth, R" sort="Hollingsworth, R" uniqKey="Hollingsworth R" first="R" last="Hollingsworth">R. Hollingsworth</name></country><country name="Australie"><noRegion><name sortKey="Cracknell, W" sort="Cracknell, W" uniqKey="Cracknell W" first="W" last="Cracknell">W. Cracknell</name></noRegion></country><country name="Belgique"><noRegion><name sortKey="Jacobs, C" sort="Jacobs, C" uniqKey="Jacobs C" first="C" last="Jacobs">C. Jacobs</name></noRegion></country><country name="États-Unis"><region name="Massachusetts"><name sortKey="Tsai, T" sort="Tsai, T" uniqKey="Tsai T" first="T" last="Tsai">T. Tsai</name></region></country><country name="Suisse"><noRegion><name sortKey="Barbosa, P" sort="Barbosa, P" uniqKey="Barbosa P" first="P" last="Barbosa">P. Barbosa</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001178 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001178 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PoplarV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28754488
|texte= Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): The 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28754488" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PoplarV1
| This area was generated with Dilib version V0.6.37. |  |